Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey

•We assessed foot-and-mouth disease (FMD) Asia-1 vaccine effectiveness in Turkey.•Retrospective cohort methods were used after village FMD outbreaks.•For the vaccine containing the FMD Asia-1 Sindh-08 antigen: vaccine effectiveness = 69% against clinical disease and 63% against infection.•The vaccin...

Full description

Bibliographic Details
Main Authors: Knight-Jones, T.J.D., Bulut, A.N., Gubbins, S., Stärk, K.D.C., Pfeiffer, D.U., Sumption, K.J., Paton, D.J.
Format: Online
Language:English
Published: Elsevier Science 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991324/
id pubmed-3991324
recordtype oai_dc
spelling pubmed-39913242014-04-18 Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey Knight-Jones, T.J.D. Bulut, A.N. Gubbins, S. Stärk, K.D.C. Pfeiffer, D.U. Sumption, K.J. Paton, D.J. Article •We assessed foot-and-mouth disease (FMD) Asia-1 vaccine effectiveness in Turkey.•Retrospective cohort methods were used after village FMD outbreaks.•For the vaccine containing the FMD Asia-1 Sindh-08 antigen: vaccine effectiveness = 69% against clinical disease and 63% against infection.•The vaccine containing FMD Asia-1 Shamir antigen did not protect. Elsevier Science 2014-04-01 /pmc/articles/PMC3991324/ /pubmed/24530150 http://dx.doi.org/10.1016/j.vaccine.2014.01.071 Text en © 2014 Published by Elsevier Ltd. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Knight-Jones, T.J.D.
Bulut, A.N.
Gubbins, S.
Stärk, K.D.C.
Pfeiffer, D.U.
Sumption, K.J.
Paton, D.J.
spellingShingle Knight-Jones, T.J.D.
Bulut, A.N.
Gubbins, S.
Stärk, K.D.C.
Pfeiffer, D.U.
Sumption, K.J.
Paton, D.J.
Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey
author_facet Knight-Jones, T.J.D.
Bulut, A.N.
Gubbins, S.
Stärk, K.D.C.
Pfeiffer, D.U.
Sumption, K.J.
Paton, D.J.
author_sort Knight-Jones, T.J.D.
title Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey
title_short Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey
title_full Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey
title_fullStr Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey
title_full_unstemmed Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey
title_sort retrospective evaluation of foot-and-mouth disease vaccine effectiveness in turkey
description •We assessed foot-and-mouth disease (FMD) Asia-1 vaccine effectiveness in Turkey.•Retrospective cohort methods were used after village FMD outbreaks.•For the vaccine containing the FMD Asia-1 Sindh-08 antigen: vaccine effectiveness = 69% against clinical disease and 63% against infection.•The vaccine containing FMD Asia-1 Shamir antigen did not protect.
publisher Elsevier Science
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991324/
_version_ 1612079692491259904